Found 183 matching trials
A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18 PHASE1 The purpose is to identify a dose of SB-485232 which is safe, tolerable and...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia PHASE2 This phase II trial studies how well a dose adjusted regimen consisting of ...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine PHASE2 This study is designed to compare the number of infusion reactions to treat...
Show More Location
St.Joseph Heritage Care
Learn More & Join Trial
Treatment -Resistant Neovascular Age-Related Macular Degeneration PHASE1 The purpose of this study is to determine if treatment of Age Related Macul...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma PHASE2 This is a single-arm, prospective clinical study to evaluate the efficacy a...
Show More Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma PHASE2 RATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and de...
Show More Location
University of Alabama at Birmingham Comprehensive Cancer Center
Learn More & Join Trial
TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) PHASE4 This multicenter randomized, open-label study aim to compare the efficacy a...
Show More Location
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma PHASE3 B-cell non-Hodgkin's lymphoma (B-NHL) is the most common type of NHL. Altho...
Show More Location
Shandong Provincial Hospital
Learn More & Join Trial
Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies PHASE2 This is a Phase II trial to evaluate the efficacy and safety of human leuko...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL PHASE1 The purpose of this study is to determine the safety of lenalidomide (revli...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial